Skip to main content

Small Pharma Inc(DMT-X)
TSX Venture

Today's Change
Real-Time Last Update

Canadian Patent Grant Strengthens Small Pharma’s International Position

Globe Newswire - Wed Aug 3, 2022

LONDON, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today announces that as of July 19, 2022 it has been granted patent no. 3104072 by the Canadian Intellectual Property Office.


Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.